Upgrade to SI Premium - Free Trial

Marker Therapeutics (MRKR)

1.27 +0.03 (2.42%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/19/26)

Latest Headlines

H.C. Wainwright Reiterates Buy Rating on Marker Therapeutics (MRKR) July 10, 2026 6:51 AM - StreetInsider H.C. Wainwright Reiterates Buy Rating on Marker Therapeutics (MRKR) May 20, 2026 6:49 AM - StreetInsider Form 10-Q Marker Therapeutics, For: Mar 31 May 15, 2026 5:01 PM - SEC Filing Form 8-K Marker Therapeutics, For: May 01 May 4, 2026 4:31 PM - SEC Filing Full Article List